Overview

The Role of Melatonin as an Adjuvant Therapy in Childhood Pneumonia

Status:
RECRUITING
Trial end date:
2026-01-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to compare the mean length of hospital stay between children with pneumonia receiving melatonin as an adjuvant therapy and those receiving standard of care alone. The hypothesis is that combining oral melatonin with standard treatment can reduce the length of hospital stay as compared to standard of care alone. The control group will receive standard treatment (antibiotic) while the intervention group will receive standard treatment plus melatonin for 14 days.
Phase:
PHASE1
Details
Lead Sponsor:
Mian Muhammad Hassan Ahmed
Treatments:
Melatonin